NCT00220142
Completed
Not Applicable
Molecular Markers of Prognosis in Colorectal Cancer Patients
ConditionsColorectal Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Colorectal Cancer
- Sponsor
- Royal Marsden NHS Foundation Trust
- Enrollment
- 103
- Locations
- 1
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
To correlate the molecular profile of a series of defined CRCs with prognosis and toxicity.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients participating in the RMHNHST study of infusional versus bolus 5FU (Saini et al. 2003).
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
A Cohort of Molecular Characteristics and Prognosis of Colorectal CancerColorectal CancerSurgeryNCT05086601Fudan University15,000
Recruiting
Not Applicable
Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer ProgressionColorectal CancerNCT03309722University of Southampton1,000
Unknown
Not Applicable
Colorectal Cancer Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in ChinaColorectal NeoplasmColorectal CancerAdenomatous PolypsAdenomaAdvanced AdenomaSerrated PolypNCT04515082Changhai Hospital4,800
Active, not recruiting
Not Applicable
Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and PolypColorectal CancerColorectal AdenomaNCT05638542Seoul National University Bundang Hospital582
Unknown
Not Applicable
Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma.Colorectal NeoplasmsMicrobiotaPrognosisMetabolic SyndromeSarcopeniaNCT03843905University Hospital, Clermont-Ferrand300